Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Understanding when and how to adjust a zero based budget helps you stay aligned with goals. Explore timing, methods, and best practices.
28,655 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
MongoDB stock is under pressure again, with shares dropping sharply amid a broad market sell-off. This article breaks...
A new proposal aims to end blind signing in Ethereum wallets. The change could reduce scam losses and tighten securit...
A routine voicemail from a faux sheriff’s officer could cost families thousands. This guide explains how the 'lieuten...
When a tech titan backs a biotech startup, investors take note. This article digs into whether Jeff Bezos backed Grai...
Viking Holdings (VIK) 2025 reveals how the company navigated a mixed year. This analysis breaks down Q4 results, marg...
A clear, investor-friendly look at HireQuest's Q1 2026 performance and what the numbers signal for HQI's earnings tra...
A bold revenue target from Micron points to a surprisingly durable AI demand wave. This piece breaks down what the gu...
Even with a stunning 19x profit surge, Samsung's stock slipped. This article breaks down why the market reacted this ...
February brought an 11% slide in main street capital stock as investors weighed private credit risk and rising rates....
Ford surprised markets with an upward revision to its 2026 guidance after a solid first quarter. This article breaks ...
Micron Technology surged to a fresh all-time high after a blockbuster earnings report and strong AI-driven demand. Th...